{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:07:42Z","timestamp":1792519662430,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022030","name":"Silence Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.atherosclerosis.2022.07.015","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T04:05:47Z","timestamp":1659413147000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality"],"prefix":"10.1016","volume":"357","author":[{"given":"Morten","family":"Kaltoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Sofia","family":"Glavind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune Fallgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Langsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper Karmark","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge Gr\u00f8nne","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-6762","authenticated-orcid":false,"given":"Pia R\u00f8rb\u00e6k","family":"Kamstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib1","series-title":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at","author":"Hopkins University & Medicine","year":"2020"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib2","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: a plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib6","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044640","article-title":"Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies","volume":"11","author":"Pijls","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"67","author":"Kamstrup","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib9","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","article-title":"Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis","volume":"22","author":"Moriarty","year":"2020","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00041433-200308000-00004","article-title":"Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside","volume":"14","author":"Marcovina","year":"2003","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2009.12.036","article-title":"Lipoprotein(a) and ischemic heart disease-a causal association? A review","volume":"211","author":"Kamstrup","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated lipoprotein(a) and risk of ischemic stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pcad.2020.04.004","article-title":"What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?","volume":"63","author":"Cybulska","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, lp(a) lipoprotein, and coronary artery disease, N","volume":"353","author":"Tsimikas","year":"2005","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17305\/bjbms.2010.2728","article-title":"Lipoprotein (a) as an acute phase reactant in patients on chronic hemodialysis","volume":"10","author":"Topciu Shufta","year":"2010","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/330113a0","article-title":"Teaching old dogmas new tricks","volume":"330","author":"Brown","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.78.4.615","article-title":"Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo","volume":"78","author":"Nielsen","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib20","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0735-1097(98)00469-0","article-title":"Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation","volume":"32","author":"Dangas","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib22","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaophthalmol.2018.3499","article-title":"Survival analysis and the immortal time bias","volume":"136","author":"Kollman","year":"2018","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib24","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand. J. Stat."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib25","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.thromres.2012.06.005","article-title":"Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform","volume":"130","author":"Undas","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11239-018-1769-0","article-title":"Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties","volume":"47","author":"Skuza","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib27","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0021-9150(89)90218-9","article-title":"Transient changes of serum lipoprotein(a) as an acute phase protein","volume":"78","author":"Maeda","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5455\/medarh.2015.69.232-235","article-title":"Correlation of inflammation and lipoprotein (a) with hypercoagulability in hemodialysis patients","volume":"69","author":"Topciu-Shufta","year":"2015","journal-title":"Med. Arch."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): Diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/joim.13338","article-title":"Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events","volume":"291","author":"Di Maio","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2021.12.008","article-title":"Lipoprotein(a), venous thromboembolism and COVID-19: a pilot study","volume":"341","author":"Nurmohamed","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.atherosclerosis.2022.07.015_bib35","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/jc.2015-1096","article-title":"Elevated lipoprotein(a) does not cause low-grade inflammation despite causal association with aortic valve stenosis and myocardial infarction: a study of 100,578 individuals from the general population","volume":"100","author":"Langsted","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022013703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022013703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:26:44Z","timestamp":1762187204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022013703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":35,"alternative-id":["S0021915022013703"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.07.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}